Case Study Highlights Price Transparency Issues in U.S. Healthcare Market
Steady: 1 in the last 7 days
Updated monday
The latest in this situation
- Aon plc has released a forecast regarding medical inflation rates in Kenya.
- States and the Supreme Court raised concerns over medicine price disparity as NPPA and DGHS finalize regulatory actions.
- Private care providers are setting higher prices for placements in Southampton.
- Higher hospital and specialist fees are squeezing medical schemes due to provider pricing power and limited scheme negotiation ability.
- Hospitals in New Mexico operate within a regulated healthcare market subject to state price transparency rules.
How it started
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A case study detailed in a report involved Stephanie Campbell needing a hip replacement at Piedmont Medical Center in Fort Mill. The procedure was estimated to cost nearly $125,000. The couple was unaware of the potential cost increase, and the provider stated they could not offer a self-pay discount. Research professor Sabrina Corlette noted that wildly variant prices for common procedures are common across the country.
From wbtv.com
Why it matters
The incident highlights the issue of price transparency in U.S. healthcare services. The lack of clear pricing structures and the provider's inability to offer discounts illustrate how high costs can arise without negotiation power or market oversight.
From wbtv.com
Who's involved
- Adam KayBritish physician and comedy writer
How it developed
Newest first. Tap a step to see who reported it.- Higher hospital and specialist fees are squeezing medical schemes due to provider pricing power and limited scheme negotiation ability.Sub-event
- Hospitals in New Mexico operate within a regulated healthcare market subject to state price transparency rules.Sub-event
- The health insurance market is facing issues due to a lack of transparency and the absence of stringent price control laws regarding medicine pricing.Sub-event
General lack of price transparency noted in US healthcare services.1 source